Semaglutide
Also known as: Ozempic · Wegovy · Rybelsus
Semaglutide is a prescription medication or prescription-only peptide topic. Use this page to understand what it is used for, what side effects to ask about, and how it fits into a clinician-guided plan.
Extensively studied across the SUSTAIN and STEP trial programs. Among the most evidence-backed weight loss interventions ever developed.
What to know before you go deeper
A GLP-1 medication that helps you feel full sooner, keeps food in the stomach longer, supports blood sugar control, and reduces appetite signals.
Approval status: FDA Approved. It still requires the right indication, prescription, and follow-up.
Weight loss, Type 2 diabetes management, Cardiovascular risk reduction.
What evidence applies to my situation, what monitoring is needed, and what safer first steps should I try?
Why People Ask About Semaglutide
- Weight loss
- Type 2 diabetes management
- Cardiovascular risk reduction
Questions to Bring Up
Prescription GLP-1 medication with label-based titration and monitoring by a licensed prescriber.
Dosing, sourcing, and suitability questions belong with a licensed clinician who can review your history, labs, medications, and goals.
Known Side Effects
- Nausea (most common, especially early)
- Constipation
- Hair shedding (telogen effluvium)
- Muscle loss without resistance training
- Fatigue
Important Safety Notes
Prescription only — requires a licensed prescriber
Compounded semaglutide is not FDA-approved as a finished drug product; ask about pharmacy source and clinical need
Do not use if you have a personal or family history of medullary thyroid carcinoma or MEN2
What Is Approved?
FDA-approved for type 2 diabetes (Ozempic) and chronic weight management (Wegovy). Rybelsus is the oral form approved for diabetes.
Your feedback helps us improve the guide.